newsfilter
← Latest News
GlobeNewswire·

Invitation to the presentation of ALK’s first nine months (Q3) 2026 results on Tuesday, 17 November 2026

  • ALK will publish its Q3 2026 results on Tuesday, 17 November 2026.
  • The investor presentation will occur at 3:30 p.m. CET.
  • Management representatives include Peter Halling, Claus Steensen Sølje, & Per Plotnikof.
  • A live audio webcast will be available for replay on the company website.
  • Telephone participants must register via the provided link to receive dial-in details from diamondpass@choruscall.com.
  • The presentation slides will be posted on ALK's website shortly before the meeting.
  • ALK is a global allergy-focused pharmaceutical company with approximately 2,800 employees & a headquarters in Denmark.
Company
ALK Abello
Keywords
Copenhagen Stock Exchange:ALK B, ALK Abello